SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017204
Filing Date
2022-08-15
Accepted
2022-08-15 06:27:17
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q idya-20220630.htm   iXBRL 10-Q 3350588
2 EX-31.1 idya-ex31_1.htm EX-31.1 19405
3 EX-31.2 idya-ex31_2.htm EX-31.2 19006
4 EX-32.1 idya-ex32_1.htm EX-32.1 16457
  Complete submission text file 0000950170-22-017204.txt   9456245

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT idya-20220630_def.xml EX-101.DEF 177650
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idya-20220630_lab.xml EX-101.LAB 422995
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idya-20220630_pre.xml EX-101.PRE 307500
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT idya-20220630_cal.xml EX-101.CAL 39648
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idya-20220630.xsd EX-101.SCH 49132
56 EXTRACTED XBRL INSTANCE DOCUMENT idya-20220630_htm.xml XML 1621501
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38915 | Film No.: 221162202
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences